| BAT3 |
gene |
2 |
1 |
|
| Bax |
gene |
2 |
1 |
BCL2-associated X protein |
| BCA protein assay kit |
drug |
2 |
1 |
|
| B cells |
cohort |
5 |
2 |
B lymphocytes, CD3+CD19+ B cells |
| Bcl11b |
gene |
5 |
3 |
CTIP2, Ctip2 |
| Bcl2 |
gene |
5 |
4 |
Bcl-2, Bcl2, bcl2 protein |
| BD |
phenotype |
5 |
4 |
Bipolar disorder, bipolar disorder |
| Bdnf |
gene |
48 |
38 |
Bdnf, Brain-Derived Neurotrophic Factor, Brain-derived neurotrophic factor, brain derived neurotrophic factor, brain-derived neurotrophic factor, brain-derived neurotropic factor, brain‑derived neurotrophic factor, mature BDNF, proBDNF |
| Beagle |
drug |
4 |
2 |
BEAGLE version 3.3.1, Beagle 3.3.1, Beagle duo/trio method, Beagle haplotypes, Beagle v4.0 r1399 |
| Beck Depression Inventory |
phenotype |
3 |
3 |
BDI, BDI-II |
| BECs |
phenotype |
2 |
2 |
blood ethanol concentration, blood ethanol concentrations |
| beer |
drug |
19 |
9 |
alcohol, beer excise tax |
| behavior |
phenotype |
29 |
15 |
behavioral outcome, behavioral traits, child behavior, outcome, subsequent behavior |
| behavioral abnormalities |
phenotype |
6 |
5 |
|
| Behavioral addictions |
phenotype |
2 |
— |
|
| behavioral consequences |
phenotype |
3 |
2 |
behavioral effects, behavioral outcomes |
| behavioral control |
phenotype |
5 |
4 |
CE in RT, behavioral manifestations of control, control estimates |
| behavioral deficits |
phenotype |
12 |
6 |
behavioral deficits, behavioral impairment, behavioral symptoms, long-term behavioral impairments, short-term behavioral impairments, spatial memory deficits |
| behavioral development |
phenotype |
3 |
3 |
|
| behavioral disinhibition |
phenotype |
14 |
13 |
BD, behavioral disinhibition, disinhibition |
